CDMO / synthesis is crying but management says that they have delivered all what they had in hand and going forward also..
CDMO revenue can't be in linear growth scale & will be lumpy
CDMO : active projects are ~60
CDMO / BIO revenue contribution was ~20% in last FY & it can scale upto ~50% in 5 years
Margins will improve from current levels
no guidance on quarterly basis & we need to consider annual guidance only
